Literature DB >> 1849276

Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells.

A Aperia1, J Fryckstedt, L Svensson, H C Hemmings, A C Nairn, P Greengard.   

Abstract

Dopamine inhibits Na+,K(+)-ATPase activity in several renal tubule segments and thereby regulates urinary Na+ excretion. We now show that a phosphopeptide of 31 amino acids, corresponding to residues 8-38 of the protein phosphatase inhibitor DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of Mr 32,000), mimics the inhibitory action of dopamine on Na+,K(+)-ATPase activity in renal tubule cells from the ascending limb of the loop of Henle. The dephosphorylated form of the peptide is ineffective. The results indicate that dopamine acts through a protein phosphorylation pathway to regulate the activity of an ion pump. In addition, the data suggest that inhibition of protein phosphatase 1 by phophorylated DARPP-32 is a component of the mechanism by which dopamine regulates urinary Na+ excretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849276      PMCID: PMC51326          DOI: 10.1073/pnas.88.7.2798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism.

Authors:  A M Bertorello; J F Hopfield; A Aperia; P Greengard
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

Review 2.  The dopamine receptor in adult and maturing kidney.

Authors:  R A Felder; C C Felder; G M Eisner; P A Jose
Journal:  Am J Physiol       Date:  1989-09

3.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.

Authors:  B Meister; J Fryckstedt; M Schalling; R Cortés; T Hökfelt; A Aperia; H C Hemmings; A C Nairn; M Ehrlich; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 4.  The Na,K-pump.

Authors:  J C Skou
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

5.  Hypoxia of the renal medulla.

Authors:  F H Epstein
Journal:  Q J Med       Date:  1985-12

6.  Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.

Authors:  H C Hemmings; A C Nairn; J I Elliott; P Greengard
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

7.  Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.

Authors:  S Halpain; J A Girault; P Greengard
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

8.  Differential expression and enzymatic properties of the Na+,K(+)-ATPase alpha 3 isoenzyme in rat pineal glands.

Authors:  A W Shyjan; V Ceña; D C Klein; R Levenson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect.

Authors:  A Bertorello; T Hökfelt; M Goldstein; A Aperia
Journal:  Am J Physiol       Date:  1988-06

10.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution.

Authors:  H C Hemmings; P Greengard
Journal:  J Neurosci       Date:  1986-05       Impact factor: 6.167

View more
  16 in total

1.  Calcineurin mediates alpha-adrenergic stimulation of Na+,K(+)-ATPase activity in renal tubule cells.

Authors:  A Aperia; F Ibarra; L B Svensson; C Klee; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme.

Authors:  A M Bertorello; A Aperia; S I Walaas; A C Nairn; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.

Authors:  F Desdouits; J C Siciliano; A C Nairn; P Greengard; J A Girault
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Renal cortical basolateral Na+/HCO3- cotransporter. III. Evidence for a regulatory protein in the inhibitory effect of protein kinase A.

Authors:  A A Bernardo; F T Kear; J A Stim; Y Y Qiu; O S Ruiz; H Weidman; J A Arruda
Journal:  J Membr Biol       Date:  1995-05       Impact factor: 1.843

5.  cGMP modulates transport across the ciliary epithelium.

Authors:  D A Carré; M M Civan
Journal:  J Membr Biol       Date:  1995-08       Impact factor: 1.843

6.  Cyclic AMP mediates inhibition of the Na(+)-K+ electrogenic pump by serotonin in tactile sensory neurones of the leech.

Authors:  S Catarsi; R Scuri; M Brunelli
Journal:  J Physiol       Date:  1993-03       Impact factor: 5.182

7.  Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.

Authors:  C Chen; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

8.  A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.

Authors:  G L Snyder; A A Fienberg; R L Huganir; P Greengard
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 9.  The role of protein phosphorylation in renal amino acid transport.

Authors:  I Zelikovic; J Przekwas
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

10.  Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2.

Authors:  T Satoh; H T Cohen; A I Katz
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.